市場調査レポート - 119574

世界の体外照射療法市場

Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY
発行 Life Science Intelligence, Inc.
出版日 ページ情報 英文  
価格
世界の体外照射療法市場 Market Agent: 2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY
出版日: 2011年05月01日 ページ情報: 英文

当サービスは、世界の体外照射療法市場に関する包括的市場インテリジェンスソリューションで、高品質で詳細な最新データを提供しています。

第1章 既存の技術と特徴と新興技術

  • 既存技術の特徴
  • 既存技術の課題
    • 適合性
    • 無酸素組織
      • 経済的要因
        • 償還と国の政策や取組み
        • システム価格と関連費用
        • 世界経済

第2章 米国の体外照射療法市場

  • 市場予測：2007〜2013年
  • サプライヤーシェア：2008年
  • 線形加速器およびガンマ線装置市場の影響因子
  • 米国の体外照射療法：線形加速器およびガンマ線装置：2007〜2013年
  • 線形加速器およびガンマ線装置における米国のシェア：2008年
  • 米国のシステム別市場予測：2007〜2013年
  • 線形加速器およびガンマ線装置：2008年および2013年
  • 不況の影響：線形加速器およびガンマ線装置
  • 体外照射療法とSRS市場：2007〜2013年
  • 体外照射療法とSRS市場の影響因子：2007〜2013年
  • 用途別市場予測：2007〜2013年
  • SRSおよび体外照射療法装置：2008年および2013年
  • 不況の影響：SRS装置
  • 定位的放射線治療：米国患者人数：2007〜2013年
  • 定位的放射線治療：米国タイプ別患者動向：2007〜2013年
  • 頭蓋外定位的放射線治療：米国患者人数：2007〜2013年
  • 定位的放射線治療：米国の処置件数：2007〜2013年
  • 定位的放射線治療：米国のタイプ別処置件数：2007〜2013年
  • 不況の影響：頭蓋外定位的放射線治療
  • 体外照射療法で治療した乳癌・肺癌・前立腺癌患者数：2007〜2013年
  • 陽子線治療：米国市場予測：2007〜2013年
  • 陽子線治療装置：米国サプライヤーシェア：2008年
  • 陽子線治療：患者動向：2007〜2013年
  • 陽子線治療：米国処置件数：2007〜2013年

第3章 米国以外の体外照射療法市場

第4章 合併・買収・提携

第5章 新興企業

目次

Abstract

“2011 GLOBAL MARKETS FOR EXTERNAL RADIATION THERAPY” is a comprehensive, total market intelligence solution designed for senior executives who are looking for:

  • High quality, granular, deeply segmented data
  • Access to senior LSI analysts to conduct proprietary modeling and custom market simulations
  • Access to useable source data for in-house customization and adoption of market models

This product is a complete market intelligence solution.

The deliverables include:

  • Initial report with most recent data available (PDF and Excel)
  • Extensive access to senior LSI analyst for proprietary add-on analysis
  • Online platform making the data useable and interactive

About Life Science Intelligence

Life Science Intelligence (LSI) delivers high quality market reports, market agents, procedure databases, company databases, online partnering events, and custom consulting services to medical technology executives, investors, and entrepreneurs. LSI produces its own information products and partners with select top-tier information companies to distribute their products.

Table of Contents

1. ESTABLISHED AND EMERGING TECHNOLOGIES

  • 1.1. Features of Established Technologies
  • 1.2. Challenges for Established Technologies
    • 1.2.1. Conformality
    • 1.2.2. Anoxic Tissues
      • 1.2.2.1. Economic Factors
        • 1.2.2.1.1. Reimbursement and National Policies and Initiatives
        • 1.2.2.1.2. System Prices & Associated Costs
        • 1.2.2.1.3. The Global Economy
  • Exhibit 1-1: External Radiation Therapy by Type
  • Exhibit 1-2: Advantages and Disadvantages of External Radiation Therapy Systems
  • Exhibit 1-3: Features of Linear Accelerator and Gamma-Ray Systems Used for External Radiation Therapy and SRS
  • Exhibit 1-4: Features of Particle Therapy Centers
  • Exhibit 1-5: Challenges Associated with Available Technologies
  • Exhibit 1-6: Established and Emerging Technologies

2. U.S. MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 2-1: External Radiation Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-2: External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 2-3: Factors Influencing the U.S. Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 2-4: U.S. External Radiation Therapy, Linear Accelerators & Gamma-Ray Systems, 2007-2013
  • Exhibit 2-5: Linear Accelerator & Gamma-Ray Systems, U.S. Shares, 2008
  • Exhibit 2-6: U.S. Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 2-7: Linear Accelerator and Gamma-Ray Systems, 2008 & 2013
  • Exhibit 2-8: Impact of the Recession: Gamma-Ray Systems and Linear Accelerators, 2007-2013
  • Exhibit 2-9: Factors Influencing the U.S. Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 2-10: External Radiation Therapy, U.S. Market Forecast by Application, 2007-2013
  • Exhibit 2-11: SRS and External Radiation Systems, 2008 & 2013
  • Exhibit 2-12: Impact of the Recession: SRS Systems, 2007-2013
  • Exhibit 2-13: Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-14: Stereotactic Radiosurgery - U.S. Patient Volumes by Type, 2007-2013
  • Exhibit 2-15: Stereotactic Radiosurgery - Utilization by Patient Type, 2007-2013
  • Exhibit 2-16: Extracranial Stereotactic Radiosurgery - U.S. Patient Volumes, 2007-2013
  • Exhibit 2-17: Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-18: Stereotactic Radiosurgery - U.S. Procedures by Type, 2007-2013
  • Exhibit 2-19: Stereotactic Radiosurgery - Utilization by Procedure, 2007-2013
  • Exhibit 2-20: Extracranial Stereotactic Radiosurgery - U.S. Procedure Volumes, 2007-2013
  • Exhibit 2-21: Impact of the Recession: External Radiation Therapy Systems, 2007-2013.
  • Exhibit 2-22: New Cancer Cases in the U.S by Anatomical Location, 2007-2013
  • Exhibit 2-23: Breast, Lung and Prostate Patients Treated with External Radiation Therapy in the U.S., 2007-2013
  • Exhibit 2-24: Other Patients Treated with External Radiation Therapy, 2007-2013
  • Exhibit 2-25: External Radiation Therapy in the U.S., Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 2-26: Other External Radiation Therapy Procedures in the U.S., 2007-2013
  • Exhibit 2-27: Factors Influencing the U.S. Market for Proton Therapy, 2007-2013
  • Exhibit 2-28: Proton Therapy, U.S. Market Forecast, 2007-2013
  • Exhibit 2-29: Proton Therapy Systems, U.S. Supplier Shares in 2008
  • Exhibit 2-30: Proton Therapy, U.S. Patient Volumes, 2007-2013
  • Exhibit 2-31: Proton Therapy, U.S. Procedure Volumes, 2007-2013

3. OUS MARKETS FOR EXTERNAL RADIATION THERAPY

  • Exhibit 3-1: External Radiation Therapy, OUS Market Forecast, 2007-2013
  • Exhibit 3-2: OUS External Radiation Therapy, Supplier Shares, 2008
  • Exhibit 3-3: Factors Influencing the OUS Market for Linear Accelerator & Gamma-Ray Systems from 2007-2013
  • Exhibit 3-4: External Radiation Therapy in Europe, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-5: Linear Accelerator & Gamma-Ray Systems, European Shares in 2008
  • Exhibit 3-6: European Market Forecast by Type of System, Linear Accelerator and Gamma-Ray Systems, 2007-2013
  • Exhibit 3-7: Linear Accelerator and Gamma-Ray Systems in Europe, 2008 & 2013
  • Exhibit 3-8: AP & ROW External Radiation Therapy, Linear Accelerator & Gamma-Ray Systems, 2007-2013
  • Exhibit 3-9: Linear Accelerator & Gamma-Ray Systems, AP & ROW Shares, 2008
  • Exhibit 3-10: AP & ROW Market Forecast by Type of System, Gamma-Ray & Linear Accelerator Systems, 2007-2013
  • Exhibit 3-11: Gamma-Ray & Linear Accelerator Systems in AP&ROW, 2008 & 2013
  • Exhibit 3-12: Factors Influencing the OUS Market for External Radiation Therapy and SRS from 2007-2013
  • Exhibit 3-13: External Radiation Therapy, European Market Forecast by Application, 2007-2013
  • Exhibit 3-14: SRS and External Radiation Systems in Europe, 2008 & 2013
  • Exhibit 3-15: Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-16: Stereotactic Radiosurgery - European Patient Volumes by Type, 2007-2013
  • Exhibit 3-17: Stereotactic Radiosurgery - Utilization by Patient Type in Europe, 2007-2013
  • Exhibit 3-18: Extracranial Stereotactic Radiosurgery - European Patient Volumes, 2007-2013
  • Exhibit 3-19: Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-20: Stereotactic Radiosurgery - European Procedures by Type, 2007-2013
  • Exhibit 3-21: Stereotactic Radiosurgery in Europe - Utilization by Procedure, 2007-2013
  • Exhibit 3-22: Extracranial Stereotactic Radiosurgery - European Procedure Volumes, 2007-2013
  • Exhibit 3-23: Breast, Lung and Prostate Patients Treated with Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-24: Other Patients Treated with External Radiation Therapy in Europe, 2007-2013
  • Exhibit 3-25: External Radiation Therapy in Europe, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-26: Other External Radiation Therapy Procedures in Europe, 2007-2013
  • Exhibit 3-27: External Radiation Therapy, AP & ROW Market Forecast by Application, 2007-2013
  • Exhibit 3-28: Stereotactic Radiosurgery - AP & ROW Patient Volumes, 2007-2013
  • Exhibit 3-29: Stereotactic Radiosurgery - AP & ROW Patient Volumes by Type, 2007-2013
  • Exhibit 3-30: Stereotactic Radiosurgery - AP & ROW Utilization by Type of Patients, 2007-2013
  • Exhibit 3-31: Stereotactic Radiosurgery - AP & ROW Procedure Volumes, 2007-2013
  • Exhibit 3-32: Stereotactic Radiosurgery - AP & ROW Procedures by Type, 2007-2013
  • Exhibit 3-33: Breast, Lung and Prostate Patients Treated with Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-34: Other Patients Treated with External Radiation Therapy in AP & ROW Countries, 2007-2013
  • Exhibit 3-35: External Radiation Therapy in AP & ROW Countries, Breast, Lung, and Prostate Procedures, 2007-2013
  • Exhibit 3-36: Other External Radiation Therapy Procedures in AP & ROW Countries, 2007-2013
  • Exhibit 3-37: Factors Influencing the OUS Market for Particle Therapy, 2007-2013
  • Exhibit 3-38: Particle Therapy, European Market Forecast, 2007-2013
  • Exhibit 3-39: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-40: Particle Therapy Systems, European Supplier Shares in 2008
  • Exhibit 3-41: Particle Therapy, European Patient Volumes, 2007-2013
  • Exhibit 3-42: Particle Therapy, AP & ROW Market Forecast, 2007-2013
  • Exhibit 3-43: Particle Therapy in Europe by Type, 2007-2013
  • Exhibit 3-44: Particle Therapy Systems, AP & ROW Supplier Shares in 2008
  • Exhibit 3-45: Particle Therapy, AP & ROW Patient Volumes, 2007-2013

4. MERGERS, ACQUISITIONS, AND PARTNERSHIPS

5. EMERGING COMPANIES

「世界の体外照射療法市場」は2011年05月01日にライフサイエンス・インテリジェンスより発行されました。 当レポートは税抜￥633,425より販売しています。
Back to Top